Leading the Way in Life Science Technologies

GEN Exclusives

More »


More »

For full access to this article login to GEN Select now.

February 01, 2014 (Vol. 34, No. 3)

Novel Drugs Challenge Anti-TNFs for RA Treatment

Highly Innovative Therapeutics Progressing Rapidly in Rheumatoid Arthritis Space

  • Drug developers addressing rheumatoid arthritis (RA) therapeutics are challenging well-established TNF inhibitors with new approaches that promise better efficacy and fewer side effects. Leading contenders include multiple JAK inhibitors and interleukin inhibitors, and a potassium channel blocker that has the potential to best them all. “At a really ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.